Novartis AG
NVS · NYSE
9/29/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,556,000 | $6,656,000 | $7,066,000 | $11,459,000 |
| Short-Term Investments | $197,000 | $344,000 | $130,000 | $1,892,000 |
| Receivables | $8,984,000 | $9,176,000 | $8,725,000 | $8,211,000 |
| Inventory | $6,421,000 | $6,307,000 | $5,829,000 | $5,723,000 |
| Other Curr. Assets | $3,040,000 | $3,456,000 | $3,358,000 | $2,419,000 |
| Total Curr. Assets | $28,198,000 | $25,939,000 | $25,108,000 | $29,704,000 |
| Property Plant & Equip (Net) | $11,991,000 | $11,826,000 | $11,087,000 | $10,873,000 |
| Goodwill | $25,551,000 | $25,553,000 | $24,965,000 | $24,756,000 |
| Intangibles | $29,037,000 | $29,240,000 | $27,476,000 | $26,915,000 |
| Long-Term Investments | $2,153,000 | $2,161,000 | $2,095,000 | $1,128,000 |
| Tax Assets | $5,576,000 | $5,202,000 | $5,099,000 | $4,359,000 |
| Other NC Assets | $4,783,000 | $4,474,000 | $4,111,000 | $4,511,000 |
| Total NC Assets | $79,091,000 | $78,456,000 | $74,833,000 | $72,542,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $107,289,000 | $104,395,000 | $99,941,000 | $102,246,000 |
| Liabilities | – | – | – | – |
| Payables | $4,555,000 | $4,506,000 | $4,261,000 | $4,572,000 |
| Short-Term Debt | $7,784,000 | $8,573,000 | $8,043,000 | $8,324,000 |
| Tax Payable | $3,342,000 | $2,826,000 | $2,570,000 | $2,225,000 |
| Deferred Revenue | $0 | $0 | $0 | $127,000 |
| Other Curr. Liab. | $16,319,000 | $15,809,000 | $16,745,000 | $13,444,000 |
| Total Curr. Liab. | $32,000,000 | $31,714,000 | $31,619,000 | $28,692,000 |
| LT Debt | $24,238,000 | $24,064,000 | $23,227,000 | $22,934,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2,171,000 | $2,321,000 | $2,548,000 | $2,419,000 |
| Other NC Liab. | $4,128,000 | $4,242,000 | $4,095,000 | $4,075,000 |
| Total NC Liab. | $30,537,000 | $30,627,000 | $29,870,000 | $29,428,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,904,000 | $1,853,000 | $1,803,000 | $1,803,000 |
| Total Liabilities | $62,537,000 | $62,341,000 | $61,489,000 | $58,120,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $766,000 | $766,000 | $766,000 | $793,000 |
| Retained Earnings | $43,510,000 | $41,527,000 | $39,839,000 | $0 |
| AOCI | $98,000 | -$275,000 | -$2,217,000 | -$3,255,000 |
| Other Equity | -$44,000 | -$33,000 | -$19,000 | $46,508,000 |
| Total Equity | $44,330,000 | $41,985,000 | $38,369,000 | $44,046,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $422,000 | $69,000 | $83,000 | $80,000 |
| Total Liab. & Tot. Equity | $107,289,000 | $104,395,000 | $99,941,000 | $102,246,000 |
| Net Debt | $22,466,000 | $25,981,000 | $24,204,000 | $19,799,000 |